Bayer AG
A global life science company with core competencies in healthcare and nutrition.
BAY | F
Overview
Corporate Details
- ISIN(s):
- DE0005752059 (+2 more)
- LEI:
- 549300J4U55H3WP1XT59
- Country:
- Germany
- Address:
- Kaiser-Wilhelm-Allee 1, 51373 Leverkusen
- Website:
- https://www.bayer.com/en/
- Sector:
- Manufacturing
Description
Bayer AG is a global life science company with core competencies in the fields of healthcare and nutrition. Guided by its mission "Health for all, Hunger for none," the company develops products and services to address fundamental human needs and global challenges. Its operations are divided into three main divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, which offers over-the-counter medications and supplements; and Crop Science, which provides tailored solutions for farmers including seeds, crop protection, and digital farming technologies. Bayer's activities encompass the discovery, development, manufacturing, and commercialization of its product portfolio, aiming to improve quality of life and ensure a sustainable supply of food and feed.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-14 00:00 |
Q1 statement / Q1 financial report 2024
|
English | 214.5 KB | ||
| 2024-03-05 00:00 |
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 1.5 KB | ||
| 2024-03-05 00:00 |
Annual financial report 2023
|
English | 4.2 MB | ||
| 2024-02-26 00:00 |
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 1.8 KB | ||
| 2024-01-17 00:00 |
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 9.2 KB | ||
| 2024-01-04 00:00 |
Hinweis auf Halbjahresfinanzbericht vom 01.01.2024 bis zum 30.06.2024
|
German | 6.4 KB | ||
| 2024-01-04 00:00 |
Hinweis auf Konzernabschluss vom 01.01.2023 bis zum 31.12.2023
|
German | 6.4 KB | ||
| 2024-01-04 00:00 |
Hinweis auf Jahresfinanzbericht vom 01.01.2023 bis zum 31.12.2023
|
German | 6.4 KB | ||
| 2023-12-08 00:00 |
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 3.2 KB | ||
| 2023-11-19 00:00 |
Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV
|
English | 19.8 KB | ||
| 2023-11-08 00:00 |
Q3 statement / Q3 financial report 2023
|
English | 263.0 KB | ||
| 2023-08-08 00:00 |
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2023 bis zum 30.0…
|
German | 635.4 KB | ||
| 2023-08-08 00:00 |
Half-yearly financial report 2023
|
English | 441.5 KB | ||
| 2023-05-11 00:00 |
Q1 statement / Q1 financial report 2023
|
English | 244.6 KB | ||
| 2023-04-26 00:00 |
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
|
German | 687.7 KB |
Automate Your Workflow. Get a real-time feed of all Bayer AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Bayer AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Bayer AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
